QuickView for antigen processing and presentation of exogenous peptide antigen via MHC class II (biogroup)

1. Calu-3 lung adenocarcinoma cells infected with wildtype and mutant SARS virus
2. Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
3. Follicular fluid miRNA profiles during the development of the oocyte
4. Expression data for effector T cells
5. miRNA expression profiles from osteosarcoma samples and cell lines

There were no matches for antigen processing and presentation of exogenous peptide antigen via MHC class II

1. Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
2. Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults